Annual accounts receivable:
$915.07M+$182.01M(+24.83%)Summary
- As of today (August 23, 2025), GMAB annual accounts receivable is $915.07 million, with the most recent change of +$182.01 million (+24.83%) on December 31, 2024.
- During the last 3 years, GMAB annual accounts receivable has risen by +$402.50 million (+78.52%).
- GMAB annual accounts receivable is now at all-time high.
Performance
GMAB Accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly accounts receivable:
$998.02M+$199.00M(+24.91%)Summary
- As of today (August 23, 2025), GMAB quarterly accounts receivable is $998.02 million, with the most recent change of +$199.00 million (+24.91%) on June 1, 2025.
- Over the past year, GMAB quarterly accounts receivable has increased by +$111.59 million (+12.59%).
- GMAB quarterly accounts receivable is now at all-time high.
Performance
GMAB Quarterly accounts receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
GMAB Accounts receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +24.8% | +12.6% |
| 3 y3 years | +78.5% | +83.4% |
| 5 y5 years | +104.1% | +4.0% |
GMAB Accounts receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +78.5% | at high | +83.4% |
| 5 y | 5-year | at high | +124.8% | at high | +241.5% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
GMAB Accounts receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $998.02M(+24.9%) |
| Mar 2025 | - | $799.02M(-12.7%) |
| Dec 2024 | $915.07M(+24.8%) | $915.07M(-3.1%) |
| Sep 2024 | - | $944.68M(+6.6%) |
| Jun 2024 | - | $886.44M(+30.8%) |
| Mar 2024 | - | $677.48M(-7.6%) |
| Dec 2023 | $733.07M(-10.6%) | $733.07M(-10.6%) |
| Dec 2022 | $819.77M(+59.9%) | $819.77M(+25.3%) |
| Sep 2022 | - | $654.38M(+20.3%) |
| Jun 2022 | - | $544.18M(+27.4%) |
| Mar 2022 | - | $427.08M(-16.7%) |
| Dec 2021 | $512.58M(+25.9%) | $512.58M(+2.3%) |
| Sep 2021 | - | $500.95M(+28.9%) |
| Jun 2021 | - | $388.72M(+33.0%) |
| Mar 2021 | - | $292.22M(-28.2%) |
| Dec 2020 | $407.10M(-9.2%) | $407.10M(+26.9%) |
| Sep 2020 | - | $320.87M(-66.6%) |
| Jun 2020 | - | $959.28M(+474.8%) |
| Mar 2020 | - | $166.89M(-62.8%) |
| Dec 2019 | $448.27M(+120.5%) | $448.27M(+168.5%) |
| Sep 2019 | - | $166.98M(+27.5%) |
| Jun 2019 | - | $131.00M(+23.6%) |
| Mar 2019 | - | $105.99M(-47.9%) |
| Dec 2018 | $203.28M(+117.9%) | $203.28M(+111.1%) |
| Sep 2018 | - | $96.29M(+13.5%) |
| Jun 2018 | - | $84.84M(+11.0%) |
| Mar 2018 | - | $76.43M(-18.1%) |
| Dec 2017 | $93.31M(-32.4%) | $93.31M(+54.4%) |
| Sep 2017 | - | $60.44M(-22.0%) |
| Jun 2017 | - | $77.53M(+65.8%) |
| Mar 2017 | - | $46.77M(-66.1%) |
| Dec 2016 | $138.06M | $138.06M(+359.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2016 | - | $30.04M(+38.4%) |
| Jun 2016 | - | $21.70M(-25.9%) |
| Mar 2016 | - | $29.27M(+14.4%) |
| Dec 2015 | $25.58M(+48.1%) | $25.58M(+130.6%) |
| Sep 2015 | - | $11.09M(-23.8%) |
| Jun 2015 | - | $14.56M(+14.8%) |
| Mar 2015 | - | $12.68M(-26.6%) |
| Dec 2014 | $17.28M(-31.4%) | $17.28M(+13.4%) |
| Sep 2014 | - | $15.24M(-11.8%) |
| Jun 2014 | - | $17.27M(-57.5%) |
| Mar 2014 | - | $40.66M(+61.5%) |
| Dec 2013 | $25.17M(+3.9%) | $25.17M(+22.3%) |
| Sep 2013 | - | $20.58M(+21.4%) |
| Jun 2013 | - | $16.96M(-40.5%) |
| Mar 2013 | - | $28.51M(+17.7%) |
| Dec 2012 | $24.23M(+94.9%) | $24.23M(+100.0%) |
| Jun 2012 | - | $12.11M(+34.9%) |
| Mar 2012 | - | $8.98M(-27.8%) |
| Dec 2011 | $12.43M(+6.5%) | $12.43M(+14.9%) |
| Sep 2011 | - | $10.82M(+18.6%) |
| Jun 2011 | - | $9.12M(+10.3%) |
| Mar 2011 | - | $8.28M(-29.1%) |
| Dec 2010 | $11.67M(-41.6%) | $11.67M(+94.0%) |
| Sep 2010 | - | $6.02M(-45.5%) |
| Jun 2010 | - | $11.03M(-52.5%) |
| Mar 2010 | - | $23.23M(+16.3%) |
| Dec 2009 | $19.98M(-33.8%) | $19.98M |
| Dec 2008 | $30.18M(+316.3%) | - |
| Dec 2006 | $7.25M(-15.7%) | - |
| Dec 2005 | $8.60M(+95.2%) | - |
| Dec 2004 | $4.40M(-11.6%) | - |
| Dec 2003 | $4.98M(+165.8%) | - |
| Dec 2002 | $1.88M | - |
FAQ
- What is Genmab A/S annual accounts receivable?
- What is the all time high annual accounts receivable for Genmab A/S?
- What is Genmab A/S annual accounts receivable year-on-year change?
- What is Genmab A/S quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Genmab A/S?
- What is Genmab A/S quarterly accounts receivable year-on-year change?
What is Genmab A/S annual accounts receivable?
The current annual accounts receivable of GMAB is $915.07M
What is the all time high annual accounts receivable for Genmab A/S?
Genmab A/S all-time high annual accounts receivable is $915.07M
What is Genmab A/S annual accounts receivable year-on-year change?
Over the past year, GMAB annual accounts receivable has changed by +$182.01M (+24.83%)
What is Genmab A/S quarterly accounts receivable?
The current quarterly accounts receivable of GMAB is $998.02M
What is the all time high quarterly accounts receivable for Genmab A/S?
Genmab A/S all-time high quarterly accounts receivable is $998.02M
What is Genmab A/S quarterly accounts receivable year-on-year change?
Over the past year, GMAB quarterly accounts receivable has changed by +$111.59M (+12.59%)